Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate

Overview of attention for article published in Frontiers in immunology, June 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,299 followers.

Estos hallazgos revelaron un novedoso inmunógeno con capacidad para controlar la infección por SARS-CoV-2, utilizando un mecanismo de presentación de antígeno más amplio que las vacunas aprobadas basadas únicamente en el antígeno S. #Covid #longcovid https

06 Jul 2023

Reply Repost Favourite

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate #LongCovid #pwLC https://t.co/XNUs6vy92a

05 Jul 2023

Reply Repost Favourite

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate https://t.co/VIr6fRECMg

05 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.